The development of cell and gene therapies faces immense pressure in terms of time and cost. Advanced therapy medicinal products (ATMPs) demand stringent quality control measures to ensure safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback